Dr Anderson Okafor, MD | |
1150 N 18th St Ste 300, Abilene, TX 79601-2931 | |
(325) 670-2255 | |
(325) 670-6292 |
Full Name | Dr Anderson Okafor |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 9 Years |
Location | 1150 N 18th St Ste 300, Abilene, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417308271 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | T1502 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hendrick Medical Center | Abilene, TX | Hospital |
Brownwood Regional Medical Center | Brownwood, TX | Hospital |
Coleman County Medical Center Company | Coleman, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hendrick Provider Network | 9739162181 | 231 |
News Archive
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
The Cancer Prevention and Research Institute of Texas has awarded $1.5 million to researchers at The University of Texas Health Science Center at Houston School of Public Health for a project designed to increase human papillomavirus vaccine rates among minority youth in medically underserved areas across Houston.
› Verified 6 days ago
Entity Name | Hendrick Provider Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396961322 PECOS PAC ID: 9739162181 Enrollment ID: O20040609001047 |
News Archive
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
The Cancer Prevention and Research Institute of Texas has awarded $1.5 million to researchers at The University of Texas Health Science Center at Houston School of Public Health for a project designed to increase human papillomavirus vaccine rates among minority youth in medically underserved areas across Houston.
› Verified 6 days ago
Entity Name | Hpn Physician Billing, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538656186 PECOS PAC ID: 7315357191 Enrollment ID: O20201105002661 |
News Archive
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
The Cancer Prevention and Research Institute of Texas has awarded $1.5 million to researchers at The University of Texas Health Science Center at Houston School of Public Health for a project designed to increase human papillomavirus vaccine rates among minority youth in medically underserved areas across Houston.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Anderson Okafor, MD 1150 N 18th St Ste 300, Abilene, TX 79601-2931 Ph: (325) 670-2255 | Dr Anderson Okafor, MD 1150 N 18th St Ste 300, Abilene, TX 79601-2931 Ph: (325) 670-2255 |
News Archive
Cell Medica, a leading cellular therapeutics company which develops, manufactures and markets cellular immunotherapy products for the treatment of infectious disease and cancer, is pleased to announce an exclusive license agreement and research collaboration with the Center for Cell and Gene Therapy (CAGT), Baylor College of Medicine (Houston, Texas), for the commercialization of an innovative cell-based treatment for cancers associated with the oncogenic Epstein Barr virus (EBV).
Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
The Cancer Prevention and Research Institute of Texas has awarded $1.5 million to researchers at The University of Texas Health Science Center at Houston School of Public Health for a project designed to increase human papillomavirus vaccine rates among minority youth in medically underserved areas across Houston.
› Verified 6 days ago
Lindsey Pittillo, FNP-BC Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1957 Antilley Rd, Abilene, TX 79606 Phone: 325-692-0188 | |
Dr. Ralphie Alberto Rosario Feliciano, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1665 Antilley Rd Ste 260, Abilene, TX 79606 Phone: 325-793-5223 Fax: 325-793-5236 | |
Dr. Amelia Lorenzo, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4225 Woods Pl, Abilene, TX 79602 Phone: 325-695-3252 Fax: 325-695-3414 | |
Mustapha Ali Khalife, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2000 Pine St, Abilene, TX 79601 Phone: 253-670-6340 Fax: 903-877-7825 | |
Dr. Ralph F. Heaven, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1100 N 19th St, Suite 1a, Abilene, TX 79601 Phone: 325-672-4368 Fax: 325-672-3108 | |
Mrs. Amelia Y Yeh, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3210 Antilley Rd, Abilene, TX 79606 Phone: 325-795-1600 Fax: 325-692-4780 | |
Dr. Farley Berry Graden Neasman Iii, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 6200 Regional Plz Ste 1675, Abilene, TX 79606 Phone: 325-428-4790 Fax: 325-428-5855 |